Spontaneous Hemopericardium Associated With Apixaban Use With Newly Diagnosed Malignancy and Acute Kidney Injury: A Case Report.
| Autor: | Shalhoub A; Internal Medicine, University of Central Florida, Kissimmee, USA., Masarweh OM; Internal Medicine, University of Central Florida, Kissimmee, USA., Brenner N; Internal Medicine, University of Central Florida, Kissimmee, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 May 16; Vol. 16 (5), pp. e60410. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.60410 |
| Abstrakt: | Direct oral anticoagulants have simplified the use of anticoagulation for patients and clinicians. These medications now have indications for non-valvular atrial fibrillation and venous thromboembolism and carry a lower risk of bleeding than warfarin. While bleeding complications are common amongst all anticoagulants, spontaneous hemopericardium is a rarely reported side effect of direct oral anticoagulants, previously reported in patients with concomitant malignancy or kidney injury. We present a case of a patient with recently diagnosed renal malignancy and atrial fibrillation on apixaban who developed a spontaneous hemopericardium that required a pericardial window. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Shalhoub et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|